Search Index

Second most common anaemia Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Anaemia of chronic disease 09/07/25, 10:49 Last updated: Published: 24/08/23, 16:06 Second most common anaemia This article is no. 3 of the anaemia series. Next article: sideroblastic anaemia . Previous article: Iron-deficiency anaemia. Pathogenesis The second most prevalent anaemia is anaemia of chronic disease (ACD), it is more often seen alongside chronic infections or malignancies, other causes include infections, autoimmune diseases, and transplant rejection. The pathogenesis of the condition is greatly lead by the effectiveness of the immune system, the immune response to tumour cells and pathogens is to remove and deny access to iron, which is needed to thrive. The processes are mainly thought to be mediated through cytokines such as TNF, IL-6s and IFN as well as the acute phase protein hepcidin. IL-6 is a very powerful cytokine in that it can inhibit erythropoiesis through the downregulation of gene expression; SLC4a1 reducing haemoglobin production, it increases ferratin production whilst inhibiting TNF-α, it upregulates DMT-1 which is a protein (transmembrane) involved in iron uptake in macrophages and it upregulates the production of hepcidin. Hepicidin Hepcidin is a peptide hormone, 25 amino acid chain protein, derived mainly from hepatic cells its synthesis is induced as a response to iron overload or inflammation, its presence crucial in the diagnosis of ACD. IL-6 induces hepcidin release from hepatocytes, upregulation causes the transport protein (ferroportin) degradation inhibiting iron absorption in duodenum enterocytes and macrophage recycling via upregulation of dMT-1 and mobilization of stored iron resulting in low iron plasma. Clinical presentation A patient with ACD may have low haemoglobin (Hb) and the reticulocyte index (new RBC) count may be reduced also, this is a common feature of an iron deficient anaemia. A blood film may help diagnose the underlying condition, but the red cell morphology varies greatly, less than half can be microcytic or hypochromic. Iron studies are what helps ACD stand out from the other anaemias, raised IL-6, hepcidin and ferratin are the key markers; the presence of iron results with raised ferratin and iron will be seen if a blood film is stained correctly. There may also be reduced serum iron, % saturation and TIBC. Should erythrocyte sedimentation rates be high Rouleaux’s may be seen, which are aggregations of RBC. Conclusion The most efficient way to diagnose an anaemia is through serum biomarkers in a FBC and iron studies. Hepcidin and other chemical markers play a key role in the diagnosis of ACD. Iron studies help to paint a clearer picture when diagnosing anaemias but should be supported with a medical history alongside a clinical examination, as comorbidities may influence chronic inflammatory markers. Written by Lauren Kelly Project Gallery

A basic outline Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link An introduction to stem cells and their transformative potential 09/07/25, 10:48 Last updated: Published: 06/09/24, 11:28 A basic outline This is Article 1 in a three-part series on stem cells. Next article: The role of mesenchymal stem cells . Welcome to the first article in a series of three articles about stem cells, where I will introduce stem cells and how they differentiate. Stem cells are a remarkable type of cells that can become other types. They are divided into two main categories: adult stem cells (ASCs) and pluripotent stem cells. ASCs can differentiate into cells of specific tissues and organs. Pluripotent stem cells can differentiate into all cells in the human body and can further be split into embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). ASCs are also known as non-embryonic or somatic stem cells, referring to cells that come from non-reproductive cells, not egg or sperm cells. Some examples of ASCs include mesenchymal cells, epithelial cells and skin cells. These cells are mainly used to replace and repair dead or damaged tissues and organs damaged by disease, injury or ageing. They may stay non-dividing (quiescent) but promptly differentiate in different cell types when needed. ESCs do not come from fertilised eggs but rather from the inner cell mass of a blastocyst. A blastocyst is a group of dividing cells originating from a fertilised egg 3-5 days after fertilisation. After scientists have received informed consent, the cells are fertilised in vitro, outside a living organism, such as in a laboratory. iPSCs are created in a laboratory by mixing ASCs and ESCs. Scientists generate them by transcription-factor transduction, a type of nuclear reprogramming. Nuclear reprogramming and stem cell differentiation Nuclear reprogramming is when the nucleus of a cell is introduced into the cytoplasm of a new cell. The transfer results in changes in gene expression. In 2010, scientists Shinya Yamanaka and Helen M. Blau published a review of three alternative approaches in nuclear reprogramming to restore a cell's pluripotent state: nuclear transfer, cell fusion and transcription-factor transduction. Nuclear transfer involves moving the nucleus from a specialised cell into an egg cell with no nucleus. This can be done with oocytes or fertilised eggs during specific cell cycle phases. The reprogramming factors in the egg cell activate genes in the transferred nucleus, causing the nucleus to express genes typical of embryonic stem cells. Through this process, a specialised cell can adopt the characteristics of embryonic stem cells and potentially develop into any cell type in the body. Cell fusion is when two different cells merge to form a single hybrid cell. During cell fusion, the membranes of the two cells join, allowing their contents to mix. This merging of cells can lead to combining genetic material and cellular components from both cells. Transcription-factor transduction involves introducing specific genes called transcription factors ( Oct4 , Sox2 , Klf4 and c- Myc ) into adult cells to reprogram them into iPSCs. Conclusion Stem cells have a huge potential in medicine and research due to the different types having different functions. While the process of nuclear reprogramming does pose some challenges, such as the difficulty in ensuring that reprogrammed cells are safe and don't develop into tumours, ultimately, a better understanding of the mechanisms behind this process will allow scientists to leverage the potential of these cells, allowing them to be used in regenerative medicine. Watch out for the next article in the series, where I will discuss the role of stem cells in regenerative medicine! Written by Naoshin Haque Related articles: Vertebral stem cells and tumour metastasis / iPSCs and organoids Project Gallery

Causes, symptoms, diagnosis and management Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Hypertension: a silent threat to global health Last updated: 13/03/25, 11:38 Published: 13/03/25, 08:00 Causes, symptoms, diagnosis and management Introduction Did you know that hypertension, also known as high blood pressure, is a leading cause of premature death, affecting 1.28 billion adults aged 30-79 worldwide? According to the World Health Organisation (WHO), two-thirds of these individuals live in low and middle-income countries. Despite its widespread prevalence, many people remain undiagnosed as most cases are asymptomatic, and individuals are unaware they have the condition. Hypertension can lead to serious clinical manifestations such as heart disease. It can also cause eye retinopathy, causing vision problems and kidney damage, including proteinuria. It also contributes to vascular contributions like atherosclerosis, leading to stenosis and aneurysms. It also significantly raises the risk of stroke and heart failure (Figure 1 ). Addressing hypertension through early diagnosis, improved access to treatment and lifestyle changes is essential to reducing its global burden. This article aims to explore the causes, diagnosis and treatments. What drives hypertension? Hypertension is characterised by persistently elevated BP in the systemic arteries. Blood pressure is typically presented as a ratio: systolic BP, which measures the pressure on arterial walls during heart contraction, and diastolic BP, which reflects the pressure when the heart is at rest. Hypertension is diagnosed when the systolic blood pressure is 130 mmHg or higher and/or diastolic blood pressure exceeds 80 mmHg based on multiple readings taken over time ( Figure 2 ). In contrast, secondary hypertension occurs only in 5% of cases and is caused by an underlying condition, such as kidney disease, hormonal imbalances, or vascular problems. This form of hypertension is often reversible if the underlying cause is treated. Common causes of secondary hypertension include chronic kidney disease, polycystic kidney disease, hormone excess (such as aldosterone and cortisol), vascular issues like renovascular stenosis and certain medications. Drugs that can cause secondary hypertension include chronic use of non-steroidal inflammatory drugs (NSAIDs), antidepressants and oral contraceptives. Hypertension, regardless of its cause, can be exacerbated by certain health behaviours, including excessive dietary salt, a sedentary lifestyle, heavy alcohol consumption, and diets low in essential nutrients, such as potassium. These factors contribute to the development and worsening of high blood pressure. However, blood pressure can be improved by reversing these behaviours, as well as following a diet rich in fruits and vegetables, which helps to mitigate the negative impact on blood pressure. Spotting hypertension: how it is diagnosed Hypertension is usually detected when blood pressure (BP) is measured during regular checkups. Since it often doesn’t show symptoms, all adults must check their BP regularly. The most common way to diagnose hypertension is by measuring BP several times in a doctor’s office. To get an accurate reading, BP must be measured carefully. Since BP can vary throughout the day, multiple measurements are needed. Doctors have recently started using home BP monitoring (HBPM) and ambulatory BP monitoring (ABPM) to check BP outside of the office. ABPM records BP every 20-30 minutes over 24 hours, while HBPM lets patients measure BP at home. These methods help identify conditions like 'white coat hypertension' (high BP in the doctor’s office but normal at home) or 'masked hypertension' (normal BP at the doctor’s office but high at home). When diagnosing hypertension, doctors also look for other health issues related to high BP, such as heart disease or kidney problems. If high BP is sudden or difficult to control, doctors may suspect secondary hypertension, which is caused by another condition, like kidney disease or hormonal imbalances. A thorough medical history is essential. This includes asking about past BP readings, medications, and lifestyle factors such as smoking and diet. Doctors also check for other risk factors like diabetes or high cholesterol, increasing heart disease risk. A physical exam helps confirm the diagnosis of hypertension and checks for any damage to organs like the heart and kidneys. BP should be measured on both arms and if there's a significant difference in readings, further tests may be needed. If necessary, doctors may also check for conditions like atrial fibrillation or perform ultrasounds to look for heart or kidney problems. Blood tests can also help identify risk factors, confirm or rule out secondary hypertension, and assess overall heart health. Managing hypertension, from lifestyle changes to medications Studies show that weight loss can reduce systolic blood pressure by 5 to 20 mmHg, making it an effective strategy for managing hypertension. However, the exact "ideal" body weight or Body Mass Index (BMI) for controlling blood pressure is not clearly defined, but small weight reductions can make a difference. Reducing salt intake, staying active, and managing sleep apnoea also help. While smoking does not directly raise blood pressure, quitting reduces long-term heart risks. Overall, lifestyle changes alone can cut cardiovascular events by up to 15%. Most national and international guidelines recommend the use of angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), calcium channel blockers (CCBs), and thiazide or thiazide-like diuretics as first-line pharmacological treatments for hypertension. Conclusion Hypertension is a prevalent and often silent condition with serious health consequences, including heart disease, stroke, and kidney failure. Its widespread impact on global health, particularly in low- and middle-income countries, underscores the importance of early diagnosis and proactive management. While lifestyle modifications are crucial in managing blood pressure, medications remain essential for many individuals. By raising awareness, promoting regular blood pressure checks, and ensuring access to both preventative and therapeutic measures, we can reduce the burden of hypertension and improve long-term health outcomes globally. Written by Michelle Amoah Related article: Cardiac regeneration REFERENCES Iqbal, A. M., and Jamal, S. F. (2023). Essential hypertension. In StatPearls [Internet]. StatPearls Publishing. Retrieved from [ https://www.ncbi.nlm.nih.gov/books/NBK539859/ ] Schmieder, R. E. (2010). End Organ Damage In Hypertension. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.2010.0866 Touyz, R. M., Camargo, L. L., Rios, F. J., Alves-Lopes, R., Neves, K. B., Eluwole, O., Maseko, M. J., Lucas-Herald, A., Blaikie, Z., Montezano, A. C., and Feldman, R. D. (2022). Arterial Hypertension. In Comprehensive Pharmacology (pp. 469–487). Elsevier. World Health Organization. (2023). Hypertension. Retrieved [24th January 2025], from https://www.who.int/news-room/fact-sheets/detail/hypertension Project Gallery

Elements, compounds, and mixtures make up the building blocks of materials that shape our world. Read on to uncover how atoms, molecules, and reactions are fundamental to life on Earth. Chemistry Articles Elements, compounds, and mixtures make up the building blocks of materials that shape our world. Read on to uncover how atoms, molecules, and reactions are fundamental to life on Earth. You may also like: Medicine , Pharmacology The role of chemistry in medicine Medicinal chemistry and its uses Metal organic frameworks And their potential use in cancer drug delivery The biochemistry of cancer And how integrins can be desirable targets Metal compounds In anti-cancer drugs Female Nobel prize winners What were their contributions? Drug chirality Why is it important? Green chemistry And sustainability for the future Chemistry in space exploration What is its role? Environmental impact of electrical vehicles A chemical perspective From botulism to beauty Botulinum toxins Chemistry of an atomic bomb What is the key process behind these explosions? Vitamins Discussing their importance in the body The story of pigments and dyes The chemistry in an artist's palette Zinc fingers Transcription factors regulating gene expression Emotional chemistry On a molecular basis Nuclear safety The silent protectors Modern-day chemistry And its related challenges The story of the atom The history of the atomic model Nanoparticles A probable treatment for diabetes Exploring food at the molecular level Gastronomy Next

How metal compounds can be used as anti-cancer agents Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Anticancer Metal Compounds 28/01/25, 15:02 Last updated: Published: 23/05/23, 08:17 How metal compounds can be used as anti-cancer agents Metal compounds such as platinum, cobalt and ruthenium are used as anticancer agents. Anticancer metal compound research is important as chemotherapy is not selective, being very toxic to patients damaging normal DNA cells. Such metal compounds act as anti-cancer agents with the metals being able to vary in oxidation states. Selectivity of metal compounds to target only cancer cells arises from the metals properties of varying oxidation states for redox reactions. As cancer exists in hypoxic environments, the oxidation state of the metal is able to vary releasing the cancer drug only in the cancer environment. For example prodrugs are relatively inert metal complexes with relatively high oxidation states. PtIV, and CoIII are selective carriers undergoing reduction by varying the metals oxidation state in cancerous hypoxic environments releasing anticancer drugs. CoIII reduced to CoII, PtIV reduced to PtII in hypoxic environments. CoIII two oxidation states: Cobalt (III) is kinetically inert with low-spin 3d6 configuration, CoII is labile (high-spin 3d7). When CoIII is reduced to CoII in hypoxic environments, the active molecule is released then restored to its active form killing cancer cells. Cobalt can also bind to ligands like nitrogen mustards and curcumin ligands, exhibiting redox reactivity for cancer therapy. Nitrogen mustards are highly toxic due to their DNA alkylation and cross-linking activity. In vivo they are not selective for tumour tissue however can be deactivated by coordination to CoIII, released on reduction to CoII in hypoxic tumour tissue. This reduces systemic toxicity concluding an efficient anticancer drug. Platinum anticancer metal compounds treat ovarian, cervical and neck cancer. Platinum ( Pt IV) (cisplatin) exhibits redox-mediated anticancer activity, highly effective towards tumours. Platinum causes severe side-effects for patients so PtIV prodrug is used selectively reducing tumour sites. Ruthenium is used for cancer therapy as a less toxic metal over platinum. Ruthenium targeted therapy selectively disrupts specific cellular pathways where cancer cells rely for growth and metastasis. Reduction of Ru (III) to Ru(II) selectively occurs in hypoxic reducing environments where tumours over express transferrin receptors, ruthenium binding to. Overall metal compounds for cancer treatment attracted high interest due to redox activity properties. Metal compounds are selective to cancer cells, limiting patients' side effects. Such therapy shows how inorganic chemistry is important to medicine. Written by Alice Davey Related article: MOFs in cancer drug delivery Project Gallery

Food deserts Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link How rising food prices contribute to malnutrition 09/07/25, 14:18 Last updated: Published: 18/08/23, 20:13 Food deserts Introduction Over the past year, there have been news articles explaining how food has become more expensive along with people choosing between heating their homes and paying for groceries. According to the Office for National Statistics, the yearly cost of food and non-alcoholic drink has risen to 19.1% within one year till March 2023. There are various reasons for the food price increase; some of them include Brexit, lack of agricultural productivity and weakening of the British pound. Therefore, the spending habits of the general population have shifted towards ultra-processed foods (UPFs) as they tend to be cheaper compared to minimally processed food (MPFs). Yet, UPFs are really unhealthy with a cohort study discovering that there was an increase in mortality by 18% with each additional serving. For people living in food swamps and deserts, this is a harsh reality for them and there have to be policies to properly address this. The difference between food deserts and swamps Food deserts are places where populations have limited access to healthy and affordable food (i.e. MPFs); there are factors that contribute to this phenomenon such as having lower income or geographic location whereby there is a long distance to the nearest market. However, the increase in food prices as illustrated above can even be a part of the problem. In contrast, there are food swamps, which are areas containing more businesses that sell foods lacking nutritional value, so UPFs as opposed to MPFs. This also relates to the cost of groceries because certain populations living in food swamps are likely to purchase UPFs because they are in closer proximity than MPFs, besides being cheaper. Both situations can contribute not only to obesity, but other forms of malnutrition which will be explored below. Malnutrition To suffer from malnutrition means that there is an imbalance of nutrients and can be categorised based on undernutrition or overnutrition along with disparity in macronutrients (carbohydrates, fats and proteins) and micronutrients (vitamins and minerals). Additionally, there are countries experiencing specific forms of malnutrition such as undernutrition in comparison to others due to ongoing warfare, lack of nutritional education and/or living in poverty. The impact of malnutrition on organs in Figure 1 happens because there is deficiency in certain macronutrients and/or micronutrients, which are essential in the structure and functioning of the body. Another consequence of malnutrition is weight loss because there is depletion of fat and muscle mass in the body, leading to impaired muscle function. Food deserts/ swamps and malnutrition Going back to food deserts/swamps, their impact on malnutrition can be drastic. For example, a review focusing on food insecurity (disrupted food intake/eating patterns due to low income or supplementary resources), suggested a link between malnutrition and food insecurity along with a possible association between malnutrition and gut microbiome being negatively altered, though more research is needed. Another review looking at food insecurity in both US adults and children discovered that in a food-insecure adult’s diet, they had less vegetables, fruits and dairy leading to reduced vitamins A and B6, calcium, magnesium and zinc. How do both reviews relate to food swamps/deserts? Well, populations who are food-insecure may be likely to live in areas where there is a lack of access to healthy foods (i.e. food swamps/ deserts). Conclusion Taking into account everything discussed in this article, it seems that governments in countries where food swamps/deserts are prevalent need to address this issue through effective policies. Otherwise, there could be a future where there is an increase in chronic diseases like malnutrition. There is even potential susceptibility to infectious diseases due to malfunctioning organs stemming from malnutrition. Written by Sam Jarada Related articles: Food at the molecular level / Famine-induced epigenetic changes Project Gallery

Loss aversion: the power of framing in decision-making and why we are susceptible to poor decisions Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Behavioural Economics III 06/11/25, 11:56 Last updated: Published: 15/10/24, 11:18 Loss aversion: the power of framing in decision-making and why we are susceptible to poor decisions This is article no. 3 in a series on behavioural economics. Next article- Libertarian Paternalism . Previous article- The endowment effect . In the realm of decision-making, the way information is presented can dramatically influence the choices people make. This phenomenon, known as framing, plays a pivotal role in how we perceive potential outcomes, especially when it comes to risks and rewards. We shall now explore the groundbreaking work of Tversky and Kahneman, who sought to explain how different framings of identical scenarios could lead to vastly different decisions. By examining their research, we can gain insight into why we are susceptible to making poor decisions and understand the underlying psychological mechanisms that drive our preferences. The power of framing Imagine that the UK is preparing for the outbreak of an unusual disease, which is expected to kill 600 people. Two alternative programs to combat the disease have been proposed. In a paper by Tversky and Kahneman, they examined the importance of how information is conveyed in two different scenarios. In scenario 1: If program A is adopted, 200 people will be saved. If program B is adopted, there is a 1/3 probability that 600 people will be saved and a 2/3 probability that no people will be saved. In scenario 2: If program A is adopted, 400 people will die. If program B is adopted, there is a 1/3 probability that nobody will die and a 2/3 probability that 600 people will die. Notice that both scenarios display the exact same information, but the way in which the information is displayed is different. So surely there should be no difference between the two scenarios? In fact, there is a huge difference. Scenario 2 has been given a loss frame, where the loss frame emphasises the potential negative outcomes. By taking a sidestep, we can examine why this is important. Loss aversion is the phenomenon where ‘losses loom larger gains’. In other words, if we lose something, then the negative impact of this is greater than the positive impact of an equal-sized gain. Image 1 illustrates a loss aversion function. As illustrated in the image, a loss of £100 results in a much larger negative reaction than the positive reaction of a gain of £100. To put this into perspective, imagine it’s your birthday and someone gifts you some money. You would hopefully feel quite grateful and happy, but perhaps this feeling isn’t overwhelming. On the contrary, if you soon discover that you lost your wallet or purse, which contained the same amount of money, the psychological impact is often much more severe. Losses are perceived to be much more significant than gains. Going back to the example involving the two scenarios, we see that in scenario 2, program A emphasises the death of 400 people compared to scenario 2, program B, which has a chance to lose more but also a chance to save everyone. Statistically, you should be indifferent between the two, but because the guaranteed loss of 400 people is so overwhelming, people would much rather gamble and take the chance. This same reason is why gambling is so addictive. When you lose money in a gamble, you feel compelled to not accept the loss and decide to continue betting in an effort to make back what you once had. What Kahneman and Tversky found was that in scenario 1, 72% of people chose program A, and in scenario 2, 78% of people chose program B. Clearly, how we frame a policy makes a huge difference in its popularity. By framing the information by saying “200 people will be saved” rather than “400 people will die” out of the same 600 people, our own perception is considerably different. But on a deeper level, why might this be, and why is knowing this distinction important? In my previous article on the endowment effect, we saw that once you own something, you feel possessive over it, and losing something that you have had to work for, like money, makes you feel as though that hard work has gone to waste. But this explanation struggles to translate into our example of people. In researching for this article, I came across the evolutionary psychology perspective and found it to be both interesting and persuasive. From an evolutionary perspective, loss aversion can be seen as an adaptive trait. For our ancestors, losses such as losing food or shelter could have dire consequences for survival, whereas gains such as finding extra food was certainly beneficial but not as crucial for immediate survival. Therefore, we may be hardwired to avoid any losses, which has translated into modern-day loss aversion. The reason why knowing about this is important comes up in two aspects of life. The first is in healthcare. As demonstrated at the beginning of the article, people’s decisions can be impacted by the way in which healthcare professionals and the government frame policies. By understanding this, it allows you to make your own decision on the risks and determine whether you believe it is right for you. Similarly, policymakers can shape public opinion by highlighting the benefits or costs of action or inaction such that it meets their own political agenda. So recognising loss aversion allows for more informed decision-making. Additionally, when it comes to the world of investing, people tend to keep hold of an investment that is performing badly or perhaps at a loss in the hopes that it will go back up in the future. If this belief is justified through analysis or good judgement, then deciding to hold may be a good decision; however, often loss aversion creates a false sense of hope similar to the example I gave for gambling. If you are a keen investor, it’s important to be aware of your own investment psychology so that it allows you to maintain an objective view of a company throughout the time you decide to remain invested. Evidently, understanding how we think and make decisions can play an important role in improving the choices we make in our personal and professional lives. By recognising the impact of loss aversion and framing, we can become more aware of the unconscious biases that drive us to avoid losses at all costs, even when those decisions may not be in our best interest. Whether it’s in healthcare, investing, or everyday life, cultivating this awareness allows for more rational, informed choices that better align with long-term goals rather than short-term fears. In a world where information is constantly framed to sway public opinion, knowing the psychology behind our decision-making processes is a powerful tool that can help us make wiser, more deliberate decisions. Written by George Chant REFERENCES Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981 Jan 30;211(4481):453-8. doi: 10.1126/science.7455683. PMID: 7455683. Image provided by Economicshelp.org , a link to the website: https://www.economicshelp.org/blog/glossary/loss-aversion/ Project Gallery

Since 2006 when the link between amyotrophic lateral sclerosis (ALS), frontotemporal degeneration and TDP-43 mutations was demonstrated by Arai et al., it has remained a focus in neurological academia. This is for good reason; the research boom around the role of TDP-43 in neurodegeneration has elucidated links between TDP-43, parkinsonism and frontotemporal dementia (FTD). Go Back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link TDP-43 and Me: the Neurodegenerative Impact of Gene Misplacement in Parkinsonism Last updated: 18/11/24 Published: 06/04/23 Practice and Progress in Neurology Since 2006 when the link between amyotrophic lateral sclerosis (ALS), frontotemporal degeneration and TDP-43 mutations was demonstrated by Arai et al., it has remained a focus in neurological academia. This is for good reason; the research boo m around the role of TDP-43 in neurodegeneration has elucidated link s between TDP-43, parkinsonism and frontotemporal dementia (FTD). The link between point mutations, deletions and loss of gene function in PRKN has long been established, but has yet to lead to the development of a targeted therapeutic treatment. PRKN is involved in the tagging of excess or faulty proteins with ubiquitin, which leads to degradation of the proteins in the ubiquitin/proteasome system (UPS)- a system characterised in medical neurology by its potential to cause serious neurological disorders. This places parkinsonism in a domain of neurodegenerative disorders sharing a common root in UPS dysfunction, including Alzheimer’s Disease, multiple sclerosis and Huntington’s Disease. Panda et al. (2022) demonstrated how the dysfunction of the UPS due to PRKN aberration inhibits the breakdown of the damaging TDP-43 aggregates which develop in human brains in response to mutation or stress. In healthy people, autophagic granules would attack and kill off these TDP-43 aggregates as an end result of the UPS , but due to aberrations in PRKN the UPS is inhibited in those afflicted with parkinsonism, causing neurodegeneration. The discovery of how TDP-43 and parkinsonism are linked could lead to the development of a treatment mimicking the organic catalyst of the TDP-43 aggregate breakdown to replicate UPS, reducing TDP-43 aggregate volume and by proxy, inhibiting neurodegeneration. In 2007, research by Esper et al. catalysed recognition of drug-induced Parkinsonism as severely underdiagnosed, with evidence proving even neurologists fail to effectively remember which medications cause parkinsonism. Fast halting of the inciting agent is necessary for the reversal of all parkinsonism symptoms, but in some patients, cognitive symptoms may persist for a time after the medication is stopped. In response to the novel discoveries of Panda et al. (2022), it is likely due to the aggregation of TDP-43. Another possibility is that permanent cognitive symptoms after inciting agent cessation in DIP may be due to large TDP-43 aggregates unable to be destroyed by the UPS. Further research will demonstrate whether TDP-43 aggregates become more resistant to UPS or autophagy through the progression of DIP, whether due to size or other extraneous factors. The implications of such a promising lead in neurotherapeutics for refractory parkinsonism cannot be understated. Surgical therapies have long since remained the industry standard in treating refractory parkinsonism, though this option remains prone to risk since many of those afflicted with parkinsonism are elderly, with drug-induced parkinsonism from treatment with antipsychotics, calcium channel blockers or other medications always heightening the number of the geriatric population requiring care for parkinsonism . Furthermore, the adequate treatment of those with parkinsonism in their youth could inhibit their progression to a refractory disease state in old age. Overall, the future looks very promising for those around the world suffering from all different forms of parkinsonism. Written by Aimee Wilson Related articles: A common diabetes drug treating Parkinson's disease / Lifestyle and PD risk

Completing the human genome puzzle with the missing piece Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Y chromosome unveiled 04/07/25, 13:00 Last updated: Published: 07/10/23, 13:23 Completing the human genome puzzle with the missing piece A brief history of the Human Genome Project The Human Genome Project is one of the most important biomedical research projects of the 20th Century. It aimed to sequence all the human genome and DNA, and by 2003, the Human Genome Project had generated the first sequence of the human genome, accounting for over 90% of the information. By 2022, the sequence was finalised, but it only contained information about the female genome, with two X chromosomes. The Y chromosome was missing as it contains many repetitive sequences that are not transcribed to messenger RNA, making it difficult to assemble it fully. However, due to advancements in sequencing technology, a new study in 2023 published in Nature aimed to, for the first time, assemble complete sequences of multiple human Y chromosomes from 43 unrelated males around the world. Sanger DNA sequencing method DNA sequencing is a method used to determine the exact order of DNA bases (adenine, thymine, cytosine, and guanine) within a DNA molecule. Due to the aim of the Human Genome Project (to sequence all of the DNA), many methods were experimented with, leading to scientists ultimately refining, improving and using the Sanger DNA sequencing method. This method is the most accurate method for sequencing small fragments of DNA. It involves using patient DNA in a polymerase chain reaction (PCR). A mix of normal bases and chain-terminating bases is added. Chain-terminating bases stop DNA growth, creating fragments of different lengths, each ending in a terminator. The DNA fragments are separated by size through capillary gel electrophoresis. Each terminator base (adenine, thymine, cytosine, and guanine) has a different fluorescent tag. The fragments appear in order of length, and their fluorescent tags are recorded. This information is used to create a chromatograph, which is compared to a reference to identify variants, allowing DNA analysis. Analysis of the Y chromosome In 2023, a study published in Nature assembled complete sequences of multiple human Y chromosomes from 43 unrelated males around the world. The study discovered a high level of structural variation across the Y chromosomes, which was unexpected. The analysis showed a high level of diversity of the Y chromosome, and it is the beginning of the exploration of male genetic diversity. The study highlights that the information gained can be used in various fields of biomedicine, such as to gain more insight into the function and evolution of the human genome and to understand more about Y chromosome variants. This discovery can also lead to improved genetic testing accuracy and targeted treatments for personalised medicine. Written by Naoshin Haque Project Gallery

At Scientia News, we provide free help with personal statements for students applying to UK universities. From proofreading and checking to detailed feedback reports, there is a lot of support. We check UCAS personal statements for free! What are UCAS personal statements? For UK-based universities UCAS personal statements are a chance for students to show a UK university why they should be offered a place to study a particular subject there. Academics or more? Whilst academics are important to talk about, it is just as necessary to talk about who you are beyond your grades, too. This is the third mandatory question of the statement. Page and character limited It is critical to note that the statements must not be longer than 1 page: anything beyond this will not be read. The character limit is 4000, with a minimum of 350 characters per question. You can v isit UCAS for more information... Deadline! All statements must be submitted through UCAS by 14th January 2026 at 18:00 (UK time). However, the earlier the better as universities accept students on a rolling deadline. The process of submitting a personal statement: 1. Research university courses interested in 2. Pick a course & answer the 3 statement questions 3. Check and edit statement for approval 4. Submit to your top 5 university choices Note for those that are considering medicine or dentistry: You (normally) will have to choose 1 university out of the 5 where you will do a back up course i.e. something that is not medicine or dentistry. What we offer to you: Proofreading To catch any remaining errors or inconsistencies in draft statements Expert advisors Graduates or current university students will provide personalised advice to highlight your unique qualities, and align your statement with your chosen field of study Goals We'll assist in articulating your passion and long-term goals effectively Feedback Get detailed feedback reports with specific improvement suggestions Guidance Giving example guideline questions for you to answer and include in your statement. This will help to create flow and making adjustments easier. Structure Advice on approaching your introduction, main body paragraphs and ending Examples of universities where some of our volunteers currently attend, or have graduated from: Queen Mary University of London, Imperial College London, Kings College London, University of Liverpool and so on. Fill the form out below and we will contact you* * Alternatively, you can email us at scientianewsorg@gmail.com . Please keep the subject as 'Personal Statement'. * Disclaimer: there must be no plagiarism or use of AI in all statements submitted - we will assume there has been no copying. Scientia News will not be responsible for any plagiarism or AI detection by UCAS, as we only give advice. Email Subject Your message Send Thanks for submitting!